RNAimmune
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $39M
Investors
- 7
About RNAimmune
RNAimmune, Inc.Founded in 2020 and headquartered in Gaithersburg, US, RNAimmune, Inc. specializes in developing mRNA therapeutics and vaccines., Smooth River Wealth Management, and Rotating Boulder Fund.RNAimmune specializes in innovative mRNA-based therapeutic solutions and vaccines, including personalized neoantigen vaccines for cancer, prophylactic vaccines for infectious diseases, and mRNA therapeutics targeting rare diseases. Utilizing proprietary mRNA technology, their advanced delivery systems, such as lipid nanoparticle (LNP) and polypeptide lipid nanoparticle (PLNP) formulations, effectively enhance immune responses.RNAimmune generates revenue through strategic partnerships, licensing agreements, and collaborations with pharmaceutical companies and research institutions. They have successfully licensed their RSV mRNA vaccine technology to Hualan Biological Vaccine Inc. and are involved in partnerships aimed at developing various vaccines and therapeutics.00 mn, secured in March 2022, RNAimmune plans to scale its team and advance its mRNA vaccine programs. The investment will enhance their ability to develop upcoming products, including new mRNA vaccines and therapeutics. The company is focused on expanding into new markets, particularly in regions like Europe and Asia, aiming for broader global reach by 2024.
Who invested in RNAimmune
7 investors across 3 rounds
See all investors in RNAimmune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RNAimmune
Who invested in RNAimmune?
RNAimmune has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RNAimmune raised?
RNAimmune has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did RNAimmune last raise money?
RNAimmune's most recent round on record is a Series A, in Mar 2022.
What does RNAimmune do?
RNAimmune is a biotechnology company.
Where is RNAimmune headquartered?
RNAimmune is headquartered in Gaithersburg, US.
Which VCs invest in companies like RNAimmune?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RNAimmune's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like RNAimmune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.